|
PCM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.7537999999504E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.022200E-03 |
| Normal-vs-Stage2 |
1.764430E-02 |
| Normal-vs-Stage3 |
7.8447026652384E-11 |
| Normal-vs-Stage4 |
2.81630000431576E-08 |
| Stage1-vs-Stage2 |
5.819000E-01 |
| Stage1-vs-Stage3 |
1.08149999999974E-06 |
| Stage1-vs-Stage4 |
3.406500E-04 |
| Stage2-vs-Stage3 |
3.351700E-02 |
| Stage2-vs-Stage4 |
9.445700E-02 |
| Stage3-vs-Stage4 |
5.282000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54992999999992E-05 |
| Normal-vs-AfricanAmerican |
1.235570E-03 |
| Normal-vs-Asian |
2.113900E-02 |
| Caucasian-vs-AfricanAmerican |
8.119200E-01 |
| Caucasian-vs-Asian |
5.655400E-01 |
| AfricanAmerican-vs-Asian |
4.872000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.81760000015497E-07 |
| Normal-vs-Female |
5.962900E-04 |
| Male-vs-Female |
1.906180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.397200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.012600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.68939999662032E-08 |
| Normal-vs-Age(81-100Yrs) |
2.377400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.495800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.949800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.193000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.751630E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.314400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.440800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.316160E-01 |
| Normal-vs-Grade 2 |
1.542430E-02 |
| Normal-vs-Grade 3 |
1.93119964464472E-10 |
| Normal-vs-Grade 4 |
1.96199723134782E-11 |
| Grade 1-vs-Grade 2 |
1.861560E-02 |
| Grade 1-vs-Grade 3 |
4.8748000003318E-07 |
| Grade 1-vs-Grade 4 |
8.82220000386624E-08 |
| Grade 2-vs-Grade 3 |
2.71519999994752E-06 |
| Grade 2-vs-Grade 4 |
1.4164999950772E-08 |
| Grade 3-vs-Grade 4 |
1.542320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.131800E-02 |
| Normal-vs-ccB subtype |
7.54190043750214E-10 |
| ccA subtype-vs-ccB subtype |
2.69719999668183E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.93300000004027E-06 |
| Normal-vs-N1 |
9.440800E-04 |
| N0-vs-N1 |
3.553800E-01 |
|
|
